Outcomes of Intravenous Tocilizumab Treatment for Refractory Pars Planitis.

MLA

Kongrat, Lisa, et al. “Outcomes of Intravenous Tocilizumab Treatment for Refractory Pars Planitis.” Ocular Immunology and Inflammation, May 2024, pp. 1–6. EBSCOhost, https://doi.org/10.1080/09273948.2024.2354751.

APA

Kongrat, L., Maleki, A., Rujkorakarn, P., Margolis, M. J., Valerio, T., Massoudi, Y., Anesi, S. D., & Foster, C. S. (2024). Outcomes of Intravenous Tocilizumab Treatment for Refractory Pars Planitis. Ocular Immunology and Inflammation, 1–6. https://doi.org/10.1080/09273948.2024.2354751

Chicago

Kongrat, Lisa, Arash Maleki, Ploysai Rujkorakarn, Michael J Margolis, Tate Valerio, Yasmin Massoudi, Stephen D Anesi, and C Stephen Foster. 2024. “Outcomes of Intravenous Tocilizumab Treatment for Refractory Pars Planitis.” Ocular Immunology and Inflammation, May, 1–6. doi:10.1080/09273948.2024.2354751.